Permanent link: https://www.iths.org/?p=27367
ITHS offers ESPD Awards to help translate clinically relevant research discoveries toward development of commercial products that improve human health. Projects should be designed to demonstrate or strengthen critical evidence that the envisioned product accomplishes its health-related purpose with respect to safety, efficacy, scalability, feasibility or clinical utility (i.e., proof of concept). As examples, funds for devices could be used to create or refine prototypes, evaluate usability, assist with regulatory filings, or conduct an early-stage clinical study. Funds for therapeutic products could be used to identify or develop suitable animal models, produce small batches of the product, evaluate toxicology, pharmacokinetics or pharmacodynamics or prepare for IND submission. Funds for mobile health products could be used to evaluate effects of human factors, assess interface design, develop software coding, assist with regulatory filings, or conduct an early-stage clinical trial. Funds for diagnostic products could be used for assay development, reagent formulation, device or reader prototype design, interface design, or software coding.
The following key dates apply to this funding opportunity:
This pilot award will provide up to $100,000 toward specific project-related milestones in total costs for 1 year. No-cost extensions are not permitted.
Applications will be reviewed by a panel of scientists and engineers with commercial or investment experience. Reviewers will focus on 5 primary questions. 1) To what extent does the proposed product address an unmet human health need? 2) How strong is the available evidence supporting proof of concept that the proposed product is safe, effective, scalable, feasible or of value? 3) To what extent does the project address a critical step or milestone necessary to advance a research discovery toward commercial development? 4) To what extent has the team planned and prepared for commercialization of the technology through evaluation of market considerations?? 5) Beyond this ESPD Award, what additional staffing, equipment, and funds will the project team need to reach the proposed project milestones?
1. Applicant Teams. The ESPD Award is built on the hypothesis that, with appropriate guidance and resources, academic research settings can serve as initial incubators for development of commercial health innovations. The ESPD Award is ideally suited for teams that have gone through iCore, Commercialization Bootcamp, or other similar training programs. ITHS faculty or staff may be listed as active research contributors on a case-by-case basis. Please consult with ITHS (contact below) prior to application submission if your proposal includes ITHS faculty or staff.
2. Support. This award provides up to $100,000 for 1 year of funding. The period of performance coincides with the ITHS fiscal year from March 1 to February 28/29. All grant funds must be expended before the grant expires at the end of the fiscal year. No-cost extensions to allow use of funds that have not been expended by the end of the fiscal year will not be allowed.
3. Review Considerations. The review process for full applications will involve a mandatory live-session product pitch to reviewers. ITHS will provide guidance and training for preparing these presentations. Applications should describe a trajectory of past progress, current specific aims and milestones that are feasible within the funding limits, a vision for how attainment of the proposed milestones will enable future work, and the potential scope and impact of future work if the current project is successful.
Successful applications will help reviewers determine whether the project should and could be done.
We have high interest in new and innovative generalizable solutions for common and persistent challenges in the conduct and outcomes of translational research through development of new methods, approaches, platforms, or tools that
See https://ncats.nih.gov/about/about-translational-science/principles for details.
Members at ITHS Partner Institutions, including the University of Washington, Fred Hutch Cancer Research Center, Seattle Children’s Research Institute, and other academic institutions affiliated with the ITHS in the WWAMI (Washington, Wyoming, Alaska, Montana, Idaho) region are eligible to apply for this pilot award. Collaborations may extend outside the WWAMI region; however, funds may not be transferred outside the United States. ITHS-funded faculty (those who receive salary or stipends from ITHS) and staff are ineligible to apply. Any individual eligible for external research funding according to the rules of their institution and unit may apply. Applicants who are not faculty members are required to submit a letter of support.
All Investigators on the research team must be ITHS Members to apply. Membership is free. To become a member, please complete the ITHS Membership Form.
Applicant’s primary workspace must be based in Washington, Wyoming, Alaska, Montana, or Idaho.
Applicant may be operating under other grant funding as long as the funding does not redundantly support activities or deliverables proposed in their ESPD application.
Proposed activities must be feasibly completed within the 12-month period of performance. (eg., March 20XX to February 20XX+1). Extensions are not allowed.
Funds may be used to pay for materials, contract services, and salaries for work and workers related to accomplishment of project deliverables. This requirement will generally exclude compensation for lab PI’s or company administrative staff effort, but indirect costs may also be covered when appropriate.
The letter of intent form must be submitted through the ITHS website before submission of the application. The form includes information on the applicant and any Co-Investigators, project title, and abstract addressing the 5 questions (up to 200 words each). Investigators who are invited to submit a full application will receive notice within 3 weeks of the letter of intent deadline.
The application must be submitted through the ITHS website.
Applications will follow National Institutes of Health (NIH) formatting guidelines (see FAQ) and include:
[prettyfilelink size=”138 KB” src=”https://www.iths.org/wp-content/uploads/Cover-Page-Pilot-Awards.2021b.pdf” type=”pdf”]1) Cover Page[/prettyfilelink]
2) Abstract (250 word maximum)
3) Research Plan, 6-pages (references do not count toward page limit)
[prettyfilelink size=”57 KB” src=”https://www.iths.org/wp-content/uploads/Pilot-Proposal-Timeline-Template.2018.docx” type=”doc”]4) Project Timeline – 1-page[/prettyfilelink]
5) Partnership Plan, 1-page description of the collaboration including an explanation of the respective roles of the partners and the synergy brought about by the partnership
6) Potential use of ITHS in-kind resource, complete the ITHS in-kind resources form, select “send me a copy of my responses” and submit with your application packet
7) Generalizable Solutions, up to 1-page description if applicable (see Guidelines)
8) Human Subjects, if applicable
9) Budget and Budget Justification[prettyfilelink size=”29 KB” src=”https://www.iths.org/wp-content/uploads/Pilot-Budget-Template.2018.xlsx” type=”xls inline”]9a) Budget[/prettyfilelink] [prettyfilelink size=”37 KB” src=”https://www.iths.org/wp-content/uploads/Pilot-Budget-Justification-Sample.2018.docx” type=”doc inline”]9b) Budget Justification[/prettyfilelink]
10) Letters of Support – Letters of Support are not required unless you are an instructor or acting faculty member. If you are an instructor or acting faculty member, you will need to include a letter supporting your eligibility to serve as PI from your Department head (or equivalent).
A general note about conflict of interest: Reviewers would have a conflict of interest if they are the applicant’s mentor, department chair, spouse, or close relative; or if they currently work together on manuscripts, grants, or business ventures. Simply being in the same department or division is not, in and of itself, a conflict of interest.
ITHS is funded through a CTSA grant from NIH’s National Center for Advancing Translational Sciences (NCATS). NCATS requires the review and approval of all pilot grants involving human subjects research before funds are released. Therefore, if your proposal is awarded funding and involves human subjects research, additional documentation will be required. NCATS review and IRB review can be concurrent, but final NCATS approval is contingent upon IRB approval.
[superior_faq layout=”boxed” open_icon=”plus-circle” close_icon=”minus-circle” headline_tag=”p” effect=”accordion” permalink=”yes” deeplinking=”yes” excerpt=”no” voting=”no” category_style=”display:none;” title_style=”font-weight:600;” content_style=”” categories=”188″]
For information regarding ITHS pilot programs, please contact Lindsie Boerger. Email her through the form below.
For information regarding this pilot program, contact:
Lindsie Boerger
Project Manager
Institute of Translational Health Sciences
850 Republican Street, Box 358051, Seattle, WA 98109
lboerger@uw.edu / www.iths.org
Page last modified: Oct 2, 2024 @ 10:48 am (PST)